Departments of, Department of, Pediatrics, New York Medical College, Valhalla, NY, USA.
Department of, Medicine, New York Medical College, Valhalla, NY, USA.
Br J Haematol. 2020 Sep;190(6):822-836. doi: 10.1111/bjh.16557. Epub 2020 Mar 4.
Sinusoidal obstruction syndrome (SOS), previously known as hepatic veno-occlusive disease (VOD), remains a multi-organ system complication following haematopoietic cell transplantation (HCT). When SOS/VOD is accompanied by multi-organ dysfunction, overall mortality rates remain >80%. However, the definitions related to the diagnosis and grading of SOS/VOD after HCT are almost 25 years old and require new and contemporary modifications. Importantly, the pathophysiology of SOS/VOD, including the contribution of dysregulated inflammatory and coagulation cascades as well as the critical importance of liver and vascular derived endothelial dysfunction, have been elucidated. Here we summarise new information on pathogenesis of SOS/VOD; identify modifiable and unmodifiable risk factors for disease development; propose novel, contemporary and panel opinion-based diagnostic criteria and an innovative organ-based method of SOS/VOD grading classification; and review current approaches for prophylaxis and treatment of SOS/VOD. This review will hopefully illuminate pathways responsible for drug-induced liver injury and manifestations of disease, sharpen awareness of risk for disease development and enhance the timely and correct diagnosis of SOS/VOD post-HCT.
窦状隙阻塞综合征(SOS),以前称为肝静脉阻塞病(VOD),在造血细胞移植(HCT)后仍然是多器官系统并发症。当 SOS/VOD 伴有多器官功能障碍时,总死亡率仍>80%。然而,与 HCT 后 SOS/VOD 诊断和分级相关的定义几乎已有 25 年的历史,需要进行新的和现代的修改。重要的是,SOS/VOD 的发病机制,包括失调的炎症和凝血级联反应的贡献以及肝和血管来源的内皮功能障碍的关键重要性,已经阐明。在这里,我们总结了关于 SOS/VOD 发病机制的新信息;确定了疾病发展的可改变和不可改变的危险因素;提出了新的、现代的、基于小组意见的诊断标准以及一种创新的基于器官的 SOS/VOD 分级分类方法;并回顾了目前预防和治疗 SOS/VOD 的方法。本综述有望阐明药物性肝损伤的发病途径和疾病表现,提高对疾病发展风险的认识,并提高 HCT 后 SOS/VOD 的及时和正确诊断。